Mrs. Joy Nicole Bittle, P.A.-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 714 Gravois Rd, Suite 210, Fenton, MO 63026 Phone: 314-543-5230 Fax: 314-543-5280 |
Valerie Marie Rasche, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1055 Bowles Ave Ste 200, Fenton, MO 63026 Phone: 636-496-3900 |
Mrs. Mindy Marie Carney, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 636-496-2000 |
Tyler Harrelson, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 416 Old Smizer Mill Rd, Fenton, MO 63026 Phone: 314-467-1590 Fax: 314-275-4655 |
Mrs. Lindsay K Exline, PAC Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1195 Stone Bluff Dr, Fenton, MO 63026 Phone: 707-448-2298 Fax: 707-453-1602 |
Marissa P Taylor, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 714 Gravois Rd Ste 210, Fenton, MO 63026 Phone: 636-660-9850 Fax: 636-660-9851 |
Caroline Victoria Menie, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 714 Gravois Rd Ste 115, Fenton, MO 63026 Phone: 636-717-6775 Fax: 636-717-6755 |
Ms. Beth C Weber, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 714 Gravois Rd, Ste 210, Fenton, MO 63026 Phone: 314-543-5230 Fax: 314-543-5280 |
News Archive
A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular events.
The Food and Drug Administration (FDA) in the United States says the production of a popular blood thinning drug has been halted temporarily after more than 300 reports of health problems associated with the drug.
After losing a last-minute appeal to the Supreme Court, craft stores chain Hobby Lobby said it would defy a federal health care mandate requiring employers to provide their workers with insurance that covers emergency contraceptives.
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources.
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department's Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company's flagship StrataGraft living human skin substitute tissue.
› Verified 9 days ago